ELX, Emulex Corp.
** On its second quarter fiscal 2012, ELX posted net revenues of $128.7 million, an increase of 13% year-over-year and 9% sequentially, and net income on a GAAP basis of $15.0 million, or $0.17 per diluted share, compared to a GAAP net loss of $7.2 million, or $0.08 per share, reported in the prior quarter and a GAAP net loss of $41.0 million, or $0.47 per share, reported in the same period the prior year.
ELX provides enterprise-class connectivity for servers, networks and storage devices within the data center.
More about ELX at www.Emulex.com.
WAIR, Wesco Aircraft Holdings, Inc.
** WAIR reported results for its first quarter fiscal 2012, posting record revenue of $192.6 million, an 11% increase year over year, and adjusted EBITDA of $47.4 million, compared to $44.1 million in the same period the prior year.
WAIR is reiterating its full year fiscal 2012 guidance for revenues of between $760 million and $785 million, representing a growth rate of 7% to 10% over 2011 results.
WAIR is one of the world's largest distributors and providers of comprehensive supply chain management services to the global aerospace industry.
More about WAIR at www.wescoair.com
LDL, Lydall, Inc.
LDL's subsidiary Charter Medical Ltd. reported that it received CE Mark approval on its next generation Cell Freeze Cryogenic Storage Containers for Hematopoietic Progenitor Cells.
The issuance of the approval by European regulators allows LDL's subsidiary Charter Medical to begin marketing and selling the newly designed and expanded product offering for cryogenic storage, preservation, and transfer of Hematopoietic Progenitor Cells in Europe.
These next generation storage containers offer a broad size range from 50 mL to 750 mL and have excellent durability when frozen at ultralow (-196*C) temperatures.
LDL, with operations in the U.S., France, the Netherlands and Germany and offices in Europe and Asia, focuses on specialty engineered products for the thermal/acoustical and filtration/separation markets.
More about LDL at www.lydall.com
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.